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Mitochondrial abnormalities have been documented
in Alzheimer’s disease and related neurodegenera-
tive disorders, but the causal relationship between
mitochondrial changes and neurodegeneration, and
the specific mechanisms promoting mitochondrial
dysfunction, are unclear. Here, we find that expres-
sion of human tau results in elongation of mitochon-
dria in both Drosophila and mouse neurons. Elonga-
tion is accompanied by mitochondrial dysfunction
and cell cycle-mediated cell death, which can be
rescued in vivo by genetically restoring the proper
balance of mitochondrial fission and fusion. We
have previously demonstrated that stabilization of
actin by tau is critical for neurotoxicity of the protein.
Here, we demonstrate a conserved role for actin and
myosin in regulating mitochondrial fission and show
that excess actin stabilization inhibits association of
the fission protein DRP1 with mitochondria, leading
to mitochondrial elongation and subsequent neuro-
toxicity. Our results thus identify actin-mediated
disruption of mitochondrial dynamics as a direct
mechanism of tau toxicity in neurons in vivo.
INTRODUCTION
Alzheimer’s disease (AD) is the most common neurodegenera-
tive disorder, affecting approximately 10% of people over the
age of 70 (Plassman et al., 2007). AD is characterized histopath-
ologically by deposition of Abeta peptides in extracellular
amyloid plaques and by aggregation of hyperphosphorylated
species of the microtubule-associated protein tau into neurofi-
brillary aggregates in the cytoplasm of neurons. Experimental
evidence supports the amyloid cascade hypothesis in which
Abeta peptides act upstream of tau to mediate neurodegenera-
tion in AD (Hardy and Selkoe, 2002; Ittner and Gotz, 2011).
Importantly, dominant, highly penetrant mutations in the tau
(MAPT) gene cause the familial neurodegenerative disease fron-
totemporal dementia with parkinsonism linked to chromosome
17 (FTDP-17), demonstrating an unequivocal role for tau inmedi-
ating neurodegeneration in patients (Hutton et al., 1998; Poorkaj
et al., 1998; Spillantini et al., 1998). AD and related disorders618 Neuron 75, 618–632, August 23, 2012 ª2012 Elsevier Inc.characterized by abnormal deposition of tau are collectively
termed ‘‘tauopathies.’’
Despite the substantial evidence linking tau to neurodegener-
ation, the mechanisms downstream of tau that promote
dysfunction and death of neurons are still incompletely under-
stood. A potential role for abnormalities of mitochondrial struc-
ture and function in tauopathies has been attractive for a number
of reasons. First, mitochondria are critical regulators of a variety
of important cellular processes, including ATP production and
metabolism of reactive oxygen species. Second, abnormalities
in mitochondrial function have been strongly linked to aging,
the most important risk factor for AD (Bratic and Trifunovic,
2010). In addition, mitochondrial morphological defects have
been observed in patients with AD (Hirai et al., 2001). A number
of reports have suggested dysfunction of mitochondria in tauop-
athy patients and disease models, based on reduced levels of
mitochondrial metabolic proteins, including pyruvate dehydro-
genase (Perry et al., 1980), ATP synthase (David et al., 2005),
and Complex I (Rhein et al., 2009). Although these data taken
together argue convincingly for mitochondrial abnormalities in
AD and related tauopathies, the precise nature of the funda-
mental defects and the causal role those defects play in disease
pathogenesis has been unclear.
In the current study, we demonstrate increased length of
mitochondria in animal models of tauopathy. Mitochondrial
morphology is regulated by reciprocal membrane fission and
fusion, termed mitochondrial dynamics. In mammalian cells,
outer mitochondrial membrane fusion is induced by mitofusin-
1 and mitofusin-2 (MFN1 and MFN2) and inner membrane fusion
by OPA1 (Chen et al., 2003; Cipolat et al., 2004). Mitochondrial
fission is dependent on the dynamin-related GTPase DRP1,
which is primarily cytoplasmic with a smaller fraction localizing
to the outer mitochondrial membrane (Smirnova et al., 2001).
Translocation of DRP1 from cytoplasm to mitochondria appears
to play a critical role in the regulation of fission (Frank et al.,
2001). Rare inherited neurological disorders reveal the impor-
tance of normal mitochondrial dynamics in postmitotic neurons.
Charcot-Marie-Tooth disease type 2A (CMT2A), a progressive
sensory and motor axonopathy, is caused by mutations in
MFN2 (Zu¨chner et al., 2004). Similarly, mutations in OPA1
underlie the autosomal dominant optic atrophy syndrome,
a degeneration that targets retinal ganglion cells (Alexander
et al., 2000; Delettre et al., 2000). Additionally, a severe neurode-
velopmental syndrome has been reported in a patient with
a dominant negative mutation in DRP1 (Waterham et al., 2007).
However, the contribution of abnormal mitochondrial dynamics
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Tau Induces DRP1 Mislocalizationto the pathogenesis of common neurodegenerative diseases,
like AD, has been less clear.
To take a genetic approach to the mechanisms underlying
neurodegeneration in AD and related tauopathies, we have
developed a Drosophila model that recapitulates a number of
salient features of the human disorders. Expression of wild-
type and mutant versions of human tau in flies results in aberrant
phosphorylation and aggregation of tau, progressive neurode-
generation, and early death (Wittmann et al., 2001; Jackson
et al., 2002; Nishimura et al., 2004; Khurana et al., 2010). We
have subsequently defined a number of mechanisms that are
critical for neurodegeneration in our tauopathy model. These
mechanisms are implicated in human AD and related tauopa-
thies, as well. Neurotoxicity in our system requires phosphoryla-
tion of tau as an early event (Steinhilb et al., 2007a, 2007b;
Iijima-Ando et al., 2010). Tau then directly binds to and stabilizes
actin (Fulga et al., 2007). However, the mechanism by which
actin stabilization promotes downstream mediators of neuro-
toxicity has been unclear. The molecular machinery that drives
mitochondrial dynamics is well conserved in Drosophila (Ver-
streken et al., 2005; Hwa et al., 2002). We now identify actin-
mediated DRP1 mislocalization as a critical effector of tau
neurotoxicity in postmitotic neurons and further show that
DRP1 localization to mitochondria requires the actin-based
motor protein myosin II.
RESULTS
Tau Expression Promotes Mitochondrial Elongation
in Neurons
Our Drosophila model of tauopathy is based on expression of
either wild-type or FTDP-17 linked mutant forms of tau in
neurons using the UAS/GAL4 bipartite expression system
(Brand and Perrimon, 1993) and a panneuronal driver (elav-
GAL4). In these studies, we predominantly express human tau
carrying the R406W mutation, which, unless otherwise noted,
we will refer to as ‘‘tau’’ for simplicity. We have previously found
that the enhanced toxicity observed with expression of R406W
mutant tau facilitates examination of neurodegeneration in the
aging brain, with good conservation of mechanisms underlying
neurotoxicity between mutant and wild-type forms of human
tau (Khurana et al., 2006, 2010; Fulga et al., 2007; Dias-
Santagata et al., 2007; Loewen and Feany, 2010). To examine
mitochondrial morphology in our model, we coexpressed tau
with mitochondrially localized GFP (mitoGFP) in neurons of
the adult brain. Visualizing the neuronally expressed and mito-
chondrially directed GFP reveals normal round to tubular mito-
chondria in control neurons (Figure 1A, control, arrowheads). In
contrast, mitochondria in the neurons of brains from flies ex-
pressing tau are markedly elongated (Figure 1A, tau, arrow-
heads). Quantification shows that in tau-expressing neurons
mitochondrial length is, on average, greater than twice that of
control (Figure 1A, graph). Consistent with a causative role for
altered mitochondrial dynamics in mediating tau neurotoxicity,
mitochondrial elongation precedes cell death and increases
with age (Figures S1A and S1E available online). Mitochondrial
elongation also correlates with in vivo toxicity of different forms
of tau. Expression of tauR406W induces greater mitochondrialelongation compared to expression of wild-type human tau
(tauWT) expressed at the same levels, consistent with enhanced
toxicity of tauR406W compared to tauWT (Wittmann et al., 2001;
Khurana et al., 2006). Even greater elongation is triggered by
expression of a more toxic, pseudohyperphosphorylated form
of tau (tauE14, Figure S1B) (Dias-Santagata et al., 2007; Loewen
and Feany, 2010), suggesting that mitochondrial elongation is
downstream of tau phosphorylation.
Because a significant body of evidence links abnormalities of
axonal transport to tauopathy pathogenesis (Ebneth et al., 1998;
Dixit et al., 2008; Kopeikina et al., 2011; Ittner et al., 2009), we
wondered if elongation of mitochondria in tau transgenic
animals might be a secondary effect related to a defect in trans-
port of mitochondria out of the cell body, rather than a primary
abnormality. We thus evaluated mitochondrial length following
inhibition of axonal transport of mitochondria. The miro and
milton proteins are essential for association of mitochondria
with the motor protein kinesin, which facilitates their microtu-
bule-based transport (Glater et al., 2006). Consistent with
a role for miro in mitochondrial trafficking, transgenic RNAi-
mediated reduction of miro increases the mitochondrial content
of the neuronal cell bodies. However, mitochondria in miro
knockdown neurons are not elongated (Figure 1A, miro RNAi,
arrowheads). Similarly, in clones homozygous for milton92,
a null mutation (Glater et al., 2006), mitochondria are increased
in neuronal soma but are unchanged in length (Figure S1A).
Further, reduction of miro function does not alter mitochondrial
morphology in the presence of transgenic tau but is instead
associated with increased numbers of both normal and elon-
gated mitochondria in the neuronal cell bodies, as well as
enhancement of tau neurotoxicity (Figures S1D and S1E).
Thus, elongation of mitochondria in tau transgenic animals
does not appear to be a secondary effect of axonal transport
defects.
We next determined if tau expression can alter mitochondrial
morphology in vertebrate neurons. We used a murine model of
tauopathy, rTg4510, in which human tau carrying the FTDP-17
linked P301L mutation is expressed using the CaMKIIa
promoter (Ramsden et al., 2005; Santacruz et al., 2005). To
visualize mitochondria in histologic sections from these trans-
genic mice, we performed immunofluorescent staining for ATP
synthase. We observe round to modestly tubular mitochondria
in hippocampal pyramidal neurons of control mice (Figure 1B,
control, arrowheads). In contrast, mitochondria specifically in
hippocampal pyramidal neurons, a vulnerable cell population
in these tau transgenic mice, have elongated morphology (Fig-
ure 1B, tau, arrowheads). Quantitative analysis reveals a signifi-
cant increase in mean mitochondrial length in hippocampal
neurons from tau transgenic mice (Figure 1B, graph). We
observe similar mitochondrial elongation in a second murine
model of tauopathy, K3, in which the FTDP-17-associated
mutant form of tau carrying the K369I mutation is expressed
under the control of the mThy1.2 promoter (Ittner et al., 2008).
Mitochondrial elongation is prominent in frontal cortical
neurons, which express high levels of tau in these animals (Fig-
ure S1F). Three-dimensional reconstruction of confocal fluores-
cence Z-stacks captured from Drosophila and murine neurons
affords a more detailed view of the elongated morphology andNeuron 75, 618–632, August 23, 2012 ª2012 Elsevier Inc. 619
Figure 1. Tau Expression Promotes Mito-
chondrial Elongation in Neurons In Vivo
(A) Immunofluorescent staining for GFP in neurons
of flies expressing mitochondrially targeted GFP
(mitoGFP) reveals normal round to modestly
tubular mitochondria in control flies of the geno-
type elav-GAL4/+; UAS-mitoGFP/+ (control,
arrowheads). Mitochondria in tau transgenic flies
are elongated (tau, arrowheads). Reduction of
miro (miro RNAi) increases the number of mito-
chondria in neuronal soma but does not alter
mitochondrial morphology (arrowheads). Nuclei
are stained with DAPI. Scale bar is 2 mm. Quanti-
fication of mean mitochondrial length for control
and tau transgenic neurons is displayed in the
graph. Asterisk indicates p < 0.01, unpaired t test,
n = 6. Control (ctrl) is elav-GAL4/+.
(B) Immunofluorescent staining for ATP synthase
in CA1 hippocampal neurons of control mice
demonstrates normal modestly tubular mito-
chondria (control, arrowheads). Mitochondria in
hippocampal neurons from human tau P301L
transgenic mice are elongated (tau, arrowheads).
Nuclei are stained with DAPI. Scale bar is 5 mm.
Quantification of mean mitochondrial length for
control and tau transgenic neurons is displayed in
the graph. Asterisk indicates p < 0.01, unpaired t
test, n = 3.
See also Figure S1.
Neuron
Tau Induces DRP1 Mislocalizationinterconnected organization of mitochondria induced by human
tau expression (Movies S1, S2, S3, and S4).
Reversing Mitochondrial Elongation Rescues
Neurotoxicity In Vivo
To determine if toxicity of tau to postmitotic neurons is influ-
enced by the mitochondrial elongation we observe in animal
models, we manipulated the mitochondrial dynamics machinery
genetically. We focused on DRP1 and MARF (the fly homolog of
mammalian MFN) and increased and decreased expression of
each protein. To increase net mitochondrial fission levels, we
overexpressed DRP1 and decreased levels of MARF using
transgenic RNAi. These modifications significantly reduce mito-
chondrial length in tau transgenic flies (Figure 2A). Importantly,
normalization of mitochondrial length is accompanied by signif-620 Neuron 75, 618–632, August 23, 2012 ª2012 Elsevier Inc.icant rescue of neurotoxicity, as moni-
tored with TUNEL staining to identify
dying neurons (Figure 2B). Reduction of
MARF or increase of DRP1 does not
produce significant mitochondrial short-
ening or neuronal toxicity in the absence
of human tau expression using the
genetic modifiers indicated.
We then performed genetic manipula-
tions that altered dynamics in the recip-
rocal fashion, toward increased fusion,
by overexpressing MARF or reducing
DRP1 through transgenic RNAi. When
we increase fusion, we observe a further
increase in mitochondrial length in tautransgenic flies. Enhanced mitochondrial elongation is accom-
panied by significantly increased neurodegeneration (Figure 2B).
To validate the effects of DRP1 andMARF depletion by RNAi, we
used a loss of function DRP1mutant (DRP1T26; Verstreken et al.,
2005) and a chromosomal deficiency for theMARF locus (MARF
def.; Parks et al., 2004), both of which modify mitochondrial
length and neurotoxicity in tau transgenic flies (Figures S2B
and S2C). We also find that a loss-of-function mutation in
OPA1-like (OPA1-likeS3475, Spradling et al., 1999), the fly
homolog of the mammalian OPA1 fusion gene, normalizes mito-
chondrial length and suppresses toxicity in our Drosophila tau-
opathy model (Figures S2B and S2C). No significant effect on
mitochondrial morphology or neurodegeneration is observed
when DRP1 is reduced in the absence of transgenic human tau
expression, consistent with the relatively modest reduction of
Figure 2. Genetic Modification of Mitochondrial Dynamics Influences Tau Toxicity
MARF is overexpressed using a UAS-MARF transgene (MARF OE) or reduced with transgenic RNAi (MARF RNAi). DRP1 is overexpressed using a UAS-DRP1
transgene (DRP1 OE) or reduced with transgenic RNAi (DRP1 RNAi). Tau is expressed when indicated (tau).
(A) Mitochondrial length in neurons is altered byDRP1 orMARFmanipulation in transgenic flies. n = 6 per genotype. Control (ctrl) is elav-GAL4/+;UAS-mitoGFP/+.
(B) Neuronal degeneration as assayed by TUNEL staining is modified by DRP1 or MARF manipulation. n = 6 per genotype.
(C) Oxidative stress is evaluated by quantification of dihydroethidium (DHE) fluorescence in whole mount brains and shows elevated levels in tau transgenic flies
compared to control. Quantification of DHE fluorescence in brain shows modification following DRP1 or MARF manipulation. n = 3 per genotype.
(D) Cell cycle activation asmeasured by PCNA immunostaining ismodified byDRP1 andMARFmanipulation. n = 6 per genotype. Asterisks indicate p < 0.01, one-
way ANOVA with Student-Neuman-Keuls test. Control (ctrl) in (B)–(D) is elav-GAL4/+.
See also Figure S2.
Neuron
Tau Induces DRP1 MislocalizationDRP1 expression induced by transgenic RNAi (Figure S2D).
More severe reductions of DRP1 levels cause lethality (Ver-
streken et al., 2005). In contrast, overexpression of MARF in
the absence of tau produces elongation of mitochondria (Fig-
ure 2A) and also increases TUNEL staining modestly, but signif-
icantly, above baseline (Figure 2B), supporting the sensitivity of
postmitotic neurons to disruption of normal mitochondrialdynamics. These genetic data, taken together, provide strong
support for a causal relationship between the mitochondrial
elongation observed in tau transgenic flies and tau neurotoxicity.
Oxidative stress promotes neurotoxicity in the Drosophila
model of tauopathy used here (Dias-Santagata et al., 2007)
and increased ROS production has been associated with mito-
chondrial dysfunction in tau transgenic mice (David et al.,Neuron 75, 618–632, August 23, 2012 ª2012 Elsevier Inc. 621
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correlates with oxidative stress, we monitored ROS production
in whole mount brains using the superoxide-dependent fluores-
cent probe dihydroethidium (DHE; Chang and Min, 2005). Brains
from animals expressing tau show a significant increase in
superoxide production compared with brains from controls (Fig-
ure 2C). Abnormal superoxide production is reduced toward
baseline by increasing DRP1 and reducingMARF, manipulations
that normalize mitochondrial length and prevent neuronal death.
Conversely, superoxide production is further increased in tau
transgenic flies by MARF overexpression and RNAi-mediated
knockdown of DRP1 (Figure 2C).
In our model, oxidative stress is followed by abnormal activa-
tion of the cell cycle in postmitotic neurons, which promotes cell
death (Khurana et al., 2006; Dias-Santagata et al., 2007). To
monitor cell cycle activation in the brains of tau transgenic flies,
we immunostained for proliferating cell nuclear antigen (PCNA),
an S phase marker abnormally re-expressed in human AD tissue
(Busser et al., 1998) as well as tau transgenic flies (Khurana et al.,
2006). Overexpression of DRP1 or knockdown of MARF
suppresses cell cycle activation (Figure 2D). Conversely, MARF
overexpression andDRP1 knockdown increase cell cycle activa-
tion in brains of tau transgenic flies. Western blot analysis shows
no alteration in levels of tau in genetically modified backgrounds,
confirming that manipulation of DRP1 and MARF do not alter
toxicity of tau by simply increasing or decreasing the expression
of the tau transgene (Figure S2A).
Tau Expression Blocks Mitochondrial Localization
of DRP1
We next explored the mechanism by which tau expression
promotes mitochondrial elongation. We first evaluated expres-
sion of DRP1 and MARF by real-time PCR, but did not observe
changes in mRNA levels (Figure S3A). We then examined the
subcellular localization of DRP1. Cytoplasmic DRP1 protein
must translocate to the mitochondria to drive fission (Frank
et al., 2001). To visualize DRP1 in Drosophila, we used a trans-
genic strain carrying a 9.35 kb genomic rescue construct that
has an in-frame FLAG-FIAsH-HA tag after the start codon of
DRP1 (Verstreken et al., 2005). The presence of this genomic
rescue construct does not have a statistically significant effect
on tau expression, mitochondrial length, or neuronal toxicity
(Figures S2A, S3B, and S2C), consistent with modest expression
of DRP1 from its endogenous promoter (Figure S2D). Visualizing
DRP1 by immunostaining for HA, we find that in control neurons
DRP1 signal appears in discrete foci, almost exclusively local-
ized tomitochondria (Figure 3A, control, arrowheads). Immunos-
taining for FLAG shows an equivalent DRP1 staining pattern (Fig-
ure S3D). However, in neurons from tau transgenic animals
DRP1 foci are infrequent, and the majority of mitochondria do
not colocalize with DRP1 (Figure 3A, tau, arrowheads). Signal
intensity profiles for DRP1 and mitoGFP verify the tau-mediated
inhibition of colocalization (Figure S3E). One possible explana-
tion for the lack of DRP1 localization tomitochondria in tau trans-
genic neurons is that elongated mitochondria fail to recruit DRP1
normally. To test this idea we expressedMARF in the absence of
tau. In neurons overexpressing MARF we observe the expected
increase in mitochondrial length. However, in contrast to results622 Neuron 75, 618–632, August 23, 2012 ª2012 Elsevier Inc.from tau transgenic animals, elongated mitochondria in MARF
transgenics do colocalize with DRP1 puncta (Figure 3A, MARF,
arrowheads). Thus, failure of DRP1 to localize to mitochondria
in tau transgenic neurons is not likely to be a secondary effect
of the mitochondrial elongation itself. Mitochondrial localization
of DRP1 is also retained following MARF knockdown, as well
as increased or decreased expression of DRP1 (Figure S3F).
To confirm that tau expression alters DRP1 localization, we iso-
lated cytoplasmic andmitochondrial fractions from heads of flies
expressing HA-tagged DRP1 and monitored DRP1 localization
using an antibody directed to the HA epitope. DRP1 levels are
equivalent in the total homogenate and cytoplasmic fraction of
control and tau flies. However, the mitochondrial fraction shows
specific depletion of DRP1 in tau transgenic flies (Figure 3B).
Similarly, fractionation of control and rTg4510 mouse hippo-
campus reveals reduced DRP1 in mitochondrial fractions from
tau transgenic mice compared to controls (Figure 3C). Immuno-
blotting for porin, a mitochondrial membrane protein, and
GAPDH are used to confirm enrichment of mitochondrial and
cytoplasmic proteins, respectively, during the fractionation
procedure.
Actin Stabilization Blocks Mitochondrial Localization
of DRP1
We have previously demonstrated that tau binds to and stabi-
lizes actin. Excess actin stabilization by tau is required for neuro-
toxicity (Fulga et al., 2007). To determine if increasing F-actin
level alters DRP1 localization, we overexpressed the actin nucle-
ating factor WASP using a UAS-WASP transgene (Berger et al.,
2008). We also increased expression of the actin bundling
protein forked. forked gene dosage was increased with
a genomic rescue construct (Grieshaber et al., 2001). We first
used the F-actin sensitive dye rhodamine-phalloidin in whole-
mount brains to confirm that WASP and forked increase F-actin
(Figure S4A).We then determined if stabilizing the actin cytoskel-
eton influences mitochondrial morphology and DRP1 localiza-
tion to mitochondria. We find that compared to normal control
mitochondria, mitochondria in neurons with increased expres-
sion of WASP or forked are frequently elongated (Figure 4A,
arrows). Elongated mitochondria often fail to colocalize with
DRP1, whereas normal round to tubular mitochondria maintain
DRP1 localization (Figure 4A, arrowheads). Quantitative analysis
demonstrates a significant increase in mitochondrial length re-
sulting from overexpression of WASP or forked (Figure 4A,
graph). As would be expected, increasing the expression of
WASP or forked together with human tau markedly enhances
mitochondrial elongation and neuronal toxicity, without altering
tau expression (Figures S2A, S4B, and S4C). Subcellular frac-
tionation confirms reduced localization of DRP1 to mitochondria
with increased forked gene dosage (Figure 4B).
To investigate a possible physical interaction between DRP1
and F-actin, we isolated F-actin from head homogenates of
control and forked-over-expressing flies by precipitation with
biotinylated phalloidin.Western blotting shows that DRP1 copre-
cipitates with F-actin. Stabilization of actin by forked overex-
pression substantially increases the amount of DRP1 coprecipi-
tated with biotinylated phalloidin (Figure 4C). These findings
support a direct or close physical interaction between F-actin
Figure 3. Tau Expression Blocks Mitochon-
drial Localization of DRP1
(A) Mitochondria (mitoGFP, green) and HA-tagged
DRP1, detected with an antibody to HA (red), co-
localize in control neurons (control, arrowheads).
Mitochondria in tau transgenic neurons show
markedly reduced colocalization with DRP1 (tau,
arrowheads). Elongated mitochondria produced
by overexpression of MARF retain the ability to
recruit DRP1 (MARF OE, arrowheads). Scale bar is
2 mm. Control is elav-GAL4/+; UAS-mitoGFP/+;
HA-DRP1/+.
(B) Subcellular fractionation of fly head homoge-
nates shows depletion of HA-DRP1, detected with
an antibody to HA, from the mitochondrial fraction
of tau flies (Mito, M) with equivalent levels of DRP1
in the cytoplasmic fraction (Cyto, C) or total
homogenate (Total, T). Control is elav-GAL4/+;
HA-DRP1/+, negative control (neg ctrl) is elav-
GAL4/+.
(C) Subcellular fractionation of mouse hippo-
campal homogenates shows reduction of mi-
tochondrially localized DRP1 in tau animals (Mito,
M), whereas total (Total, T) and cytoplasmic (Cyto,
C) DRP1 levels are not significantly affected. The
blots in (B) and (C) are reprobed for porin and
GAPDH to demonstrate enrichment of mitochon-
drial and cytoplasmic proteins in the appropriate
fractions. The graphs in (B) and (C) show DRP1
levels as percent of control in each fraction from
tau transgenic flies or mice. Asterisks indicate p <
0.01, one-way ANOVA with Student-Neuman-
Keuls test, n = 3.
See also Figure S3.
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F-actin and concomitant depletion of mitochondrial DRP1 in
response to increased actin stabilization.Neuron 75, 618–632Reversing Actin Stabilization
Rescues Tau-Induced
Mitochondrial Defects
Because tau stabilizes actin (Fulga et al.,
2007), and actin stabilization inhibits
mitochondrial localization of DRP1, we
postulated that tau exerts its effects on
mitochondrial structure and function via
excessive actin stabilization. To test our
hypothesis directly, we destabilized actin
in the presence of tau and monitored the
effects on mitochondrial morphology,
DRP1 localization, and neurotoxicity. To
destabilize actin, we expressed the actin
severing protein gelsolin (Yin and Stossel,
1979) using a UAS-gelsolin transgene.
We first confirmed that expression of
gelsolin reduces F-actin levels by staining
whole-mount brain preparations with
rhodamine-phalloidin (Figure S5). Over-
expression of gelsolin reduces mean
mitochondrial length, rescues neurode-generation, and decreases ROS production in tau transgenic
neurons (Figure 5A). We also find increased localization of
DRP1 to mitochondria when gelsolin is coexpressed with tau, August 23, 2012 ª2012 Elsevier Inc. 623
Figure 4. Actin Stabilization Blocks Mito-
chondrial Localization of DRP1
(A) Mitochondria (mitoGFP, green) are round to
modestly tubular in control neurons and colocalize
with HA-DRP1 (red, arrowheads). In flies over-
expressing WASP using a UAS-WASP transgene
(WASP OE) or forked using a genomic rescue
construct (forked+) mitochondria are frequently
elongated (arrows). DRP1 fails to localize to
elongated mitochondria, but DRP1 colocalization
is preserved in some mitochondria of normal
length (arrowheads). Control is elav-GAL4/+;UAS-
mitoGFP/+; HA-DRP1/+. Scale bar is 2 mm.
Quantification of mean mitochondrial length for
control, WASP OE, and forked+ is displayed in the
graph. Asterisk indicates p < 0.01, one-way
ANOVA with Student-Neuman-Keuls test. n = 6
per genotype.
(B) Subcellular fractionation shows reduced HA-
DRP1 in mitochondrial fractions of head homog-
enates from forked+ flies (Mito, M). DRP1 levels
are equivalent in cytoplasmic fractions (Cyto, C)
and total fractions (Total, T). The blot is reprobed
for porin and GAPDH to demonstrate enrichment
of mitochondrial and cytoplasmic proteins in the
appropriate fractions. DRP1 level as percent of
control is calculated for each fraction from forked
flies (graph). Control is elav-GAL4/+; HA-DRP1/+,
negative control (neg ctrl) is elav-GAL4/+. Asterisk
indicates p < 0.01, one-way ANOVA with Student-
Neuman-Keuls test, n = 3.
(C) Isolation of F-actin from control and forked+
flies by precipitation with biotinylated phalloidin
(BioPh) followed by immunoblotting for actin or
HA-DRP1 demonstrates a physical interaction
between F-actin and DRP1, which is regulated by
the stabilization state of actin. Precipitation with
noncoupled biotin controls for association speci-
ficity. Control is elav-GAL4/+; HA-DRP1/+. n = 3.
See also Figure S4.
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Tau Induces DRP1 Mislocalization(Figure 5B, arrowheads) and reduced incidence of elongated
mitochondria lacking DRP1 association (Figure 5B, arrows).
These findings overall provide strong evidence that tau blocks
DRP1 localization to mitochondria through its influence on the
actin cytoskeleton.
Actin and Myosin Are Required for Localization of DRP1
to Mitochondria
Wewondered if actin stabilization might play a more general role
in controlling the subcellular localization of DRP1. We thus
examined the localization of DRP1 and F-actin in Cos-1 cells,
an immortalized mammalian fibroblastic cell line. Visualization624 Neuron 75, 618–632, August 23, 2012 ª2012 Elsevier Inc.of F-actin using rhodamine-phalloidin
and endogenous DRP1 by immunofluo-
rescence with a DRP1 antibody reveals
colocalization of DRP1 with actin stress
fibers (Figure S6A). We next examined
the effects of actin stabilization on DRP1
and mitochondria in these cells, usingtransient transfection of the actin-stabilizing protein transgelin
(Shapland et al., 1993). We first confirmed that expression of
transgelin increases levels of F-actin by staining with rhoda-
mine-phalloidin (Figure S6B). Visualizing DRP1 by immunofluo-
rescence and mitochondria by transfection of mitochondrially
directed red fluorescent protein (mitoRFP), we find that in
control cells mitochondria are round or modestly tubular, and
DRP1 colocalizes with mitochondria (Figure 6A, control, inset).
In contrast, in transgelin-expressing cells mitochondria are
elongated, and DRP1 shows less mitochondrial colocalization
(Figure 6A, transgelin, inset). Quantitative analysis reveals
a significant increase in mean mitochondrial length in
Figure 5. Reversing Actin Stabilization Rescues Tau-Induced Mitochondrial Defects
(A) Overexpression of gelsolin using aUAS-gelsolin transgene (gelsolin OE) rescues mitochondrial morphology (mitochondrial length, left), neurotoxicity (TUNEL,
center), and oxidative stress (DHE, right) in tau transgenic animals. Control (ctrl) is elav-GAL4/+; UAS-mitoGFP/+ for (left) and elav-GAL4/+ for (center, right).
Asterisk indicates p < 0.01, one-way ANOVA with Student-Neuman-Keuls test. n = 6 per genotype for mitochondrial length and TUNEL. n = 3 for DHE.
(B) Normal mitochondria in control neurons colocalize with HA-DRP1 (control, arrowheads). Expression of tau reduces the frequency of DRP1-associated
mitochondria (tau, arrowheads) in favor of elongated mitochondria lacking DRP1 (tau, arrows). Coexpression of the actin-severing protein gelsolin with tau
reduces mitochondrial length and restores DRP1 localization to mitochondria (tau; gelsolin OE, arrowheads). Control is elav-GAL4/+; UAS-mitoGFP/+; HA-
DRP1/+. Scale bar is 2 mm.
See also Figure S5.
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Tau Induces DRP1 Mislocalizationtransgelin-expressing cells compared with controls (Figure 6A,
graph). Three-dimensional reconstruction of confocal fluores-
cence Z-stacks verifies mitochondrial elongation in responseto transgelin transfection (Movies S5 and S6). Signal intensity
profiles confirm loss of association between mitochondria and
DRP1 following transgelin expression (Figure S6C).Neuron 75, 618–632, August 23, 2012 ª2012 Elsevier Inc. 625
Figure 6. F-actin Interacts with DRP1 to
Regulate Mitochondrial Morphology
(A) Immunofluorescence of DRP1 (green) and
visualization of mitochondria with transfected mi-
tochondrially-localized RFP (mitoRFP, red) in
empty vector control shows small, round mito-
chondria colocalized with DRP1 (inset). Transgelin
transfection inhibits association of DRP1 with
mitochondria (inset), causing elongation of mito-
chondria and diffuse DRP1 localization. Scale bar
is 10 mm. Mean mitochondrial length is quantified
in the graph.
(B) Mitochondrial membrane potential measured
as percent change in TMRM fluorescence com-
pared with empty vector control shows reduced
membrane potential in response to CCCP depo-
larizing control and transgelin transfection.
Asterisk indicates p < 0.01, unpaired t test. n = 6.
See also Figure S6.
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Tau Induces DRP1 MislocalizationWe next assessed whether these changes in mitochondria
morphology correlate with a disruption of mitochondrial bioener-
getics. Measuring mitochondrial membrane potential using the
TMRM dye, we find that transgelin transfection induces
a significant reduction in membrane potential compared with
control (Figure 6B). Mitochondrial elongation, mislocalization of
DRP1, and reduced mitochondrial membrane potential also
occur in response to transient transfection of tau (Figures S6D
and S6E), comparable to the effects of expressing tau in
Drosophila neurons. These findings confirm our observation of
F-actin-mediated disruption of DRP1 localization in Drosophila
and suggest that F-actin has a fundamental regulatory role in
DRP1 localization and maintenance of proper mitochondrial
function.
We next turned our focus to potential mediators of actin-
dependent localization of DRP1 to mitochondria. Several
members of the myosin family of actin-based motor proteins
can link proteins and organelles with actin cables (Akhmanova
and Hammer, 2010). Screening loss-of-function mutations in
eight neuronally expressed Drosophila myosins, we identified
myosin II as a regulator of mitochondrial fission in fly neurons.
Zipper (zip) and spaghetti squash (sqh) are theDrosophila homo-
logs of the mammalian myosin II heavy chain and regulatory light
chain, respectively. We found that flies heterozygous for a loss-
of-function allele of either zip (zip1, Zhao et al., 1988) or sqh
(sqhAX3, Jordan and Karess, 1997) have increased numbers of
elongated neuronal mitochondria (Figure 7A, arrows). Elongated
mitochondria in zip1 or sqh AX3 mutants rarely colocalize with
DRP1, whereas normal round to tubular mitochondria maintain
DRP1 colocalization (Figure 7A, arrowheads). Quantitative anal-
ysis confirms a significant increase in mitochondrial length with
reduced levels of zip or sqh (Figure 7A, graph). Mutation of either
sqh or zip enhances tau-mediated mitochondrial elongation and
neurotoxicity, without altering tau expression (Figures S2A, S7A,
and S7B). Subcellular fractionation confirms reduced localiza-
tion of DRP1 to mitochondria in zip1 and sqhAX3 flies compared
to controls, despite comparable levels of DRP1 in the cytoplasm
(Figures 7B and 7C). These findings demonstrate a requirement
for myosin II in localizing DRP1 to mitochondria.626 Neuron 75, 618–632, August 23, 2012 ª2012 Elsevier Inc.To further characterize the contribution of myosin II to
mitochondrial fission, we examined the interaction of myosin
II, F-actin, and mitochondria. A small volume of total actin is
consistently observed in the mitochondrial fraction following
a stringent fractionation procedure from fly head homogenate,
suggesting the retention of mitochondria-bound actin. Mito-
chondria-bound actin is reduced in both zip1 and sqhAX3
mutant flies (Figures 8A and 8B, Mitochondria, input). Using
biotinylated phalloidin to precipitate F-actin from mitochondrial
fractions, we find that the level of mitochondria-associated
F-actin is also reduced by both zip1 and sqhAX3 (Figures 8A
and 8B, Mitochondria, BiotPh Precip). In cytoplasmic fractions,
the levels of total actin and precipitated F-actin are equivalent
between control and either zip1 or sqhAX3 mutants (Figures
8A and 8B, Cytoplasm). In zip1 and sqhAX3 flies, reduced asso-
ciation of mitochondria with F-actin correlates with increased
association of DRP1 with F-actin, observed by coprecipitation
of F-actin and DRP1 from total head homogenate using biotiny-
lated-phalloidin (Figures 8C and 8D). These findings suggest
that myosin II facilitates tethering of mitochondria to F-actin,
a connection that is required for mitochondria to interact with
DRP1.
To determine if myosin II has a general and conserved role in
DRP1 localization, we focused on the regulatory light chain,
MLC2. We transfected Cos-1 cells with siRNA targeting two
independent, nonoverlapping sequences in MLC2. We first
confirmed depletion of MLC2 protein by western blot analysis
(Figure S8B). We then assessed mitochondrial morphology and
the subcellular localization of DRP1. In control cells, mitochon-
dria, detected with transfected mitoRFP, are round or slightly
tubular and colocalize with DRP1. In MLC2 siRNA-transfected
cells, mitochondria are significantly elongated, and DRP1 signal
is diffuse (Figure 8E, insets, graph). MLC2 is phosphorylated by
myosin light chain kinase (MLCK), which is essential to MLC2
activity (Watanabe et al., 2007). Treatment of cells with ML-7,
a chemical inhibitor of MLCK, recapitulates the effects of
MLC2 RNAi onmitochondrial morphology and DRP1 localization
(Figure S8A, insets, graph). These results support a conserved
interaction among DRP1, myosin, and actin.
Figure 7. Myosin II Facilitates Colocaliza-
tion of DRP1 with Mitochondria
(A) In control Drosophila neurons mitochondria
(green) are short and colocalize with HA-DRP1
(red, arrowheads). Neurons from flies heterozy-
gous for zip1 or sqhAX3, loss-of-function alleles of
the Drosophila homologs of mammalian myosin II
heavy chain and regulatory light chain, respec-
tively, have elongated neuronal mitochondria that
do not associate with DRP1 (zip1 and sqhAX3,
arrows). Normal round to modestly tubular mito-
chondria often retain DRP1 (zip1 and sqhAX3,
arrowheads). Control is elav-GAL4/+; UAS-
mitoGFP/+; HA-DRP1/+. Scale bar is 2 mm. Mean
mitochondrial length is quantified in the graph.
Asterisk indicates p < 0.01, one-way ANOVA with
Student-Neuman-Keuls test. n = 6.
(B and C) Subcellular fractionation shows reduced
HA-DRP1 in mitochondrial fractions of head
homogenates from flies with reduced zip (B) or sqh
(C) levels (zip1 and sqhAX3, Mito, M). DRP1 levels
are equivalent in cytoplasmic fractions (Cyto, C)
and total fractions (Total, T). The blot is reprobed
for porin and GAPDH to demonstrate enrichment
of mitochondrial and cytoplasmic proteins in the
appropriate fractions. DRP1 level as percent of
control is calculated for each fraction (graph).
Control is elav-GAL4/+; HA-DRP1/+, negative
control (neg ctrl) is elav-GAL4/+, HA-DRP1/+, zip1
is elav-GAL4/+; zip1/+; HA-DRP1/+, sqhAX3 is elav-
GAL4/sqhAX3; HA-DRP1/+. Asterisk indicates
p < 0.01, one-way ANOVA with Student-Neuman-
Keuls test, n = 3.
See also Figure S7.
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Tau Induces DRP1 MislocalizationDISCUSSION
Here, we describe a previously unsuspected target for tau
neurotoxicity in human neurodegenerative disease: mislocaliza-Neuron 75, 618–632tion of the mitochondrial fission protein
DRP1 with subsequent failure of normal
mitochondrial dynamics control. Our
current data extend a model of the
cascade of neurotoxicity triggered by
accumulation of human tau. Previous
work from our laboratories and others
(Ahlijanian et al., 2000; Noble et al.,
2005; Steinhilb et al., 2007a, 2007b;
Iijima-Ando et al., 2010) places phos-
phorylation of tau upstream in a sequence
of cellular events, including actin stabili-
zation (Fulga et al., 2007), which lead
to neuronal death. Our new results
place tau phosphorylation upstream of
altered mitochondrial dynamics (Fig-
ure S1) and further indicate that proper
regulation of the actin cytoskeleton is
critical for localization of DRP1 to mito-
chondria and subsequent mitochondrial
fission.Here, we show a physical interaction between F-actin and
DRP1. Further, we find that myosin II is required for both locali-
zation of mitochondria to actin and DRP1 to mitochondria
(Figures 7 and 8). These results support a model in which, August 23, 2012 ª2012 Elsevier Inc. 627
Figure 8. Myosin II Links Mitochonria with F-actin
(A and B) Precipitation of F-actin with biotinylated phalloidin from isolated mitochondrial fractions of heterozygous zip1 (A, Mitochondria) and sqhAX3 (B, Mito-
chondria) fly heads followed by immunoblotting for actin reveals a depletion in mitochondria-associated F-actin compared to control (BiotPh Precip). The
depletion is also apparent in total actin (Input). Cytoplasmic F-actin and total actin levels are equivalent betweencontrol andboth zip1 and sqhAX3 flies (Cytoplasm).
The blots are reprobed for Complex Va and GAPDH to demonstrate enrichment of mitochondrial and cytoplasmic proteins in the appropriate fractions. n = 3.
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Tau Induces DRP1 MislocalizationDRP1 and mitochondria are recruited to F-actin, followed by
actin-based translocation, leading to mitochondrial localization
of DRP1 and subsequent mitochondrial fission. Excess actin
stabilization inhibits translocation and colocalization of DRP1
and mitochondria, resulting in mitochondrial elongation (Fig-
ure S8C). Having observed F-actin dependent mislocalization
of DRP1 following tau expression (Figures 3 and 5), we propose
that tau-mediated actin stabilization (Fulga et al., 2007) is suffi-
cient to mislocalize DRP1.
Previous studies have demonstrated reduced organelle
motility following excessive F-actin stabilization (Chada and
Hollenbeck, 2004; Semenova et al., 2008). Also supporting our
model, myosin II-mediated linkage of mitochondria with actin
has recently been reported (Reyes et al., 2011), and mitochon-
dria have been shown to undergo myosin-mediated transport
on actin filaments in mammalian cells (Quintero et al., 2009).
Alternatively, excessive F-actin within the cell might sequester
DRP1 away from mitochondria. However, we do not favor this
second model because destabilization of actin, like excessive
stabilization, causes DRP1 mislocalization and mitochondrial
elongation, as documented here (Figure 5) and previously re-
ported by De Vos et al. (2005).
Importantly, the mechanisms we outline here appear to be
general ones. We observe altered mitochondrial dynamics
following expression of not only FTDP-17-associated forms of
tau (Figure 1), but with expression of wild-type human tau as
well (Figure S1). Neurodegenerative tauopathies are character-
ized by deposition of both wild-type and mutant forms of tau.
Although our studies were motivated by findings in our
Drosophila model of tauopathy, our consistent results from two
mouse models of tauopathy (Figures 1 and 3; Figure S1) argue
for a conserved mechanism of tau neurotoxicity in vertebrate
systems. Similarly, whereas tau is expressed primarily in
neurons, the actin- and myosin-dependence of DRP1 localiza-
tion to mitochondria and subsequent mitochondrial fission is
most likely a general mechanism regulating mitochondrial
dynamics, as demonstrated by our experiments in Cos-1 cells
(Figures 6 and 8).
There may be additional mechanisms perturbing mitochon-
drial dynamics in AD and related tauopathies. Fibroblasts from
patients with AD have been shown to have abnormally longmito-
chondria. However, in contrast to our findings, DRP1 expression
is reduced in these fibroblasts (Wang et al., 2008). Increased
levels of S-nitrosylated DRP1 have been observed in brains
from patients with AD, although biochemical analysis supports
an activating, rather than inactivating, influence of oxidatively
modified DRP1 (Cho et al., 2009). The phosphorylation state of
DRP1 contributes to mitochondrial localization and is regulated
by a number of kinases and phosphatases, including PKA and(C and D) Coprecipitation of DRP1 and F-actin using biotinylated phalloidin in tot
change in total actin (Input) or F-actin (BiotPh Precip) levels compared to control.
F-actin. n = 3. In (A)–(D), control is elav-GAL4/+; HA-DRP1/+, zip1 is elav-GAL4/+
(E) In control Cos-1 cells transfected with mitoRFP and control siRNA mitochond
(green, inset). Transfection of either of two siRNAs targeting nonoverlapping seq
DRP1 tomitochondria (inset). Meanmitochondrial length is quantified in the graph
n = 6.
See also Figure S8.calcineurin (Merrill et al., 2011; Cereghetti et al., 2008). Interest-
ingly, inhibition of both PKA and calcineurin has been observed
in AD (Shi et al., 2011; Cook et al., 2005).
Our current findings are consistent with an important role for
properly regulated DRP1 function in maintaining postmitotic
neuronal populations and raise the important question of the
cellular mechanisms mediating neurodegeneration in response
to inadequate fission. A growing body of literature suggests
that fission is an important mechanism promoting segregation
and eventual removal of mitochondria with reduced membrane
potential by autophagy (Twig et al., 2008). Of note, mutations
in the parkinsonian syndrome-related proteins parkin and
PINK1 reveal an apparent function in the mitochondrial quality
control pathway (Youle and Narendra, 2011). Impaired mito-
chondrial fission has also been associated with altered mito-
chondrial bioenergetics (Parone et al., 2008). Indeed, we find
excess production of ROS in tau flies with elongated mitochon-
dria. We have previously shown that oxidative stress plays
a critical role in the neurotoxicity of tau (Dias-Santagata et al.,
2007). We have further shown that DNA damage leads to
inappropriate cell cycle activation and subsequent neuronal
apoptosis (Khurana et al., 2006, 2012). Thus, excess production
of ROS following insufficient mitochondrial fission represents
a plausible downstream mechanism mediating neurodegenera-
tion caused by somatodendritic tau accumulation.
In addition to a general disruption of oxidative metabolism
within the cell, there may be neuronal-specific mechanisms
that promote neuronal toxicity downstream of inadequate
fission. Mitochondria have important functions locally at
synapses, including calcium buffering and ATP production, link-
ing neuronal survival to transport of mitochondria from the point
of biogenesis in the soma to distal synaptic sites (Otera and
Mihara, 2011). A number of studies have suggested that
increased expression or altered microtubule binding of tau may
compromise axonal transport of a range of cargo, includingmito-
chondria (Ebneth et al., 1998; Dixit et al., 2008; Ittner et al., 2009;
Kopeikina et al., 2011). Consistent with these findings, we show
here that transgenic RNAi-mediated knockdown of miro, which
facilitates linkage of mitochondria to kinesin for axonal transport
(Glater et al., 2006), enhances tau toxicity (Figure S2). However,
our data further suggest that the alteration in mitochondrial
dynamics we observe is not a secondary consequence of
impaired axonal transport (Figure 1). In the context of AD, the
most common tauopathy, toxicity of Abeta peptides may further
compromise mitochondrial function (Eckert et al., 2008). Thus, in
patients, multiple pathways acting in series and in parallel may
disrupt mitochondrial homeostasis. Our current findings strongly
suggest F-actin-mediated disruption of mitochondrial fission as
an important step in the cellular cascade that promotes neuronalal head homogenate from heterozygous zip1 (C) and sqhAX3 (D) flies reveals no
However, both zip1 and sqhAX3 increase the level of DRP1 coprecipitating with
; zip1/+; HA-DRP1/+, sqhAX3 is elav-GAL4/sqhAX3; HA-DRP1/+.
ria (red) are round or modestly tubular and associated with endogenous DRP1
uences in MLC2 results in mitochondrial elongation and inhibits localization of
. Asterisk indicates p < 0.01, one-way ANOVAwith Student-Neuman-Keuls test,
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Tau Induces DRP1 Mislocalizationdysfunction and death in neurodegenerative diseases associ-
ated with tau pathology.
EXPERIMENTAL PROCEDURES
Genetics
All fly crosses and aging were performed at 25C. TUNEL, PCNA, mitochon-
drial length quantification, and ROS production were assessed in 10-day-old
flies, except where noted (Figure S1). Tau transgenic mice of the strain
rTg4510 (Ramsden et al., 2005; Santacruz et al., 2005) were analyzed at
7 months of age and K3 (Ittner et al., 2008) at 10 months of age. Controls
were littermates not carrying the rTg4510 or K3 transgenes. All procedures
were in accordance with standards approved by the appropriate institutional
animal care committees. Drosophila cDNAs for DRP1 (AT04516), MARF
(RE04414), and gelsolin (SD07495) were from the Drosophila Genomics
Resource Center and were cloned into the pUAST vector. Transgenic strains
were created by embryo injection. The panneural driver elav-GAL4 was used
in all fly experiments. We have described the human UAS-tauR406W, UAS-
tauWT, and UAS-tauE14 transgenic lines previously (Wittmann et al., 2001;
Khurana et al., 2006). Clones homozygous for the null mutation milton92
were generated using the MARCM system (Lee and Luo, 1999). The following
stocks were obtained from the Bloomington Drosophila stock center:
elav-GAL4, UAS-MARF RNAi (TRiP.JF01650), Df(1)Exel6239 (MARF def.),
DRP1T26, OPA1-likeS3475, forked+t13, zip1, and sqhAX3. Transgenic lines ex-
pressing siRNA directed to DRP1 (line #44155) and miro (line #106683) were
from the Vienna Drosophila RNAi Center. Transgenic lines were created in
the w1118 background. The following lines were kindly provided by the indi-
cated investigators: UAS-WASP, Eyal Schejter; UAS-mitoGFP, milton92,
Thomas Schwarz; and FLAG-FlAsH-HA-DRP1, Hugo Bellen.
Cell Culture and Transfection
Transient transfection of plasmid DNA and siRNA was performed using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in accordance with the
manufacturer’s instructions. TMRM and CCCP were purchased from Invitro-
gen, and ML-7 was purchased from Sigma-Aldrich (St. Louis, MO, USA).
MitoRFP and transgelin cDNAs were provided by Tom Schwarz and William
Dynan, respectively, and were expressed using the pCDNA expression vector.
MLC2 and negative control siRNA (ID# s9180, s224081, AM4611) were
purchased from Applied Biosystems (Foster City, CA, USA).
Immunocytochemistry and Histology
Paraffin sections from adult Drosophila heads and mouse brains were used for
immunostaining experiments, and secondary detection was performed using
fluorescently labeled secondary antibodies. Neuronal apoptosis was assayed
by nuclear DNA fragmentation indicated by TUNEL staining using a commer-
cially available kit (TdT FragEL, Calbiochem, San Diego, CA, USA). TUNEL-
positive cells were counted throughout the entire brain.
Confocal Microscopy
To assess mitochondrial length, Drosophila Kenyon neurons, murine pyra-
midal neurons, and Cos-1 cells were imaged by laser-scanning confocal
microscopy. In two-dimensional projections of confocal Z-stacks, individual
mitochondrion length was measured by freehand line length in ImageJ
(http://rsbweb.nih.gov/ij). F-actin levels were determined in adult fly brains
as previously described (Fulga et al., 2007). Superoxide levels were measured
in adult fly brains using dihydroethidium (Invitrogen).
Mitochondrial Fractionation
Fly heads or isolated mouse hippocampi were homogenized and centrifuged
at 8003 g to pellet debris, and the supernatant collected and centrifuged at
11,0003 g to yield a pellet containing mitochondria and supernatant contain-
ing cytoplasmic proteins. One-day-old flies were used.
Phalloidin Precipitation
Fly heads were homogenized and centrifuged at 8003 g to pellet debris. The
supernatant was incubated with 0.3 units biotinylated-phalloidin (Molecular630 Neuron 75, 618–632, August 23, 2012 ª2012 Elsevier Inc.Probes, Eugene, OR, USA) followed by precipitation with streptavidin-coupled
Dynabeads (Invitrogen). To control for nonspecific protein interactions, the
same protocol was followed with biotin in place of biotinylated phalloidin. Flies
were 1-day-old in all coprecipitations.
Immunoblotting
Samples were analyzed by 15% SDS-PAGE and immunoblotted in accor-
dance with standard protocols. All immunoblots were repeated at least three
times with similar results.
See Supplemental Experimental Procedures for detailed methods.
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures, Supplemental Experimental
Procedures, and six movies and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2012.06.026.
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